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Abstract
In this chapter, the primary focus is towards four topics related to the ultrasound (US)-
guided injection: (1) the advantages of various guided injection techniques including 
US-guided injection, (2) a brief review of recently published studies on the US-guided 
botulinum toxin type A (BoNT-A) injection in stroke patients, (3) standardized opera-
tional procedures for the US-guided injection and (4) a description of the skills neces-
sary to properly locate the probe and limb during the US-guided injection operation. 
Illustrations will be presented in the chapter to assist the readers in gaining a better 
understanding of the US-guided BoNT-A injection technique.
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1. Introduction
In the post-stroke rehabilitation setting, botulinum toxin type A (BoNT-A) represents a first-
line treatment for focal spasticity. Botulinum toxin type A is regarded as an effective treatment 
agent, and the efficacy and safety of BoNT-A injected in post-stroke patients with lower limb 
spasticity have been suggested in a few limited-scale randomized controlled trials [1, 2], as 
well as a meta-analysis study [3]. A successful and safe therapy using BoNT-A requires an 
anatomically accurate administration of BoNT-A into the muscles of the belly. One should be 
aware that BoNT-A may induce undue weakness to adjacent unaffected muscles. Knowing 
the location of the needle can help clinicians more accurately inject BoNT-A into the target 
muscle. To date, manual needle placement (MNP), electromyography (EMG), electrical stimu-
lation (ES) and ultrasound (US) guidance have all been applied during BoNT-A injection [4]. 
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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Moreover, there are less frequently used localization techniques that exist to include fluoros-
copy, computed tomography (CT) and endoscopic guidance. As a clinician, one should be 
knowledgeable of the characteristics regarding the localized injection technique and the dis-
advantages and advantage of each injection technique. Then, the clinician can determine the 
appropriate localization technique that is specifically designed for the patient under examina-
tion. The issues related to injection techniques will be discussed in the following chapter.
2. Comparisons of different guided injection techniques for BoNT-A
2.1. Manual needle placement
As presented above, there are four types of localization techniques that are traditionally used 
in clinical practice. Manual needle placement, also referred to as anatomical localization, is the 
simplest type of localization technique. This technique does not require the use of any equip-
ment, unlike the other three above-mentioned localization techniques. When using MNP for 
injection, the clinician should be knowledgeable of the positions of the bones in the proce-
dural area of the body and use palpation to identify the target muscles. To correctly inject 
patients, the physician should have a thorough understanding of the anatomical position of 
the target muscle as well as the surrounding muscles. Texts provide electromyographers with 
consistent electrode insertion sites for each muscle [5]. Following these same insertion sites 
of electrography, physicians can locate the target muscles. Sometimes, in order to verify the 
location better, the physician should use some manoeuvres and indirect signs emitted from 
passive palpation spastic muscles prior to injection.
There are several advantages of MNP localization. The most apparent advantage of this tech-
nique is that no equipment is required. A small-gauge needle is used to complete the injection 
instead of the larger-gauge needles that are required with EMG or ES injection. Moreover, 
the use of a smaller needle may decrease the level of discomfort. In addition, MNP localiza-
tion is a relatively quick method that can be utilized to reduce the injection duration. Several 
disadvantages surface when MNP localization is used alone. The large, superficial muscles 
may be easily distinguishable with anatomic localization alone; however, other small, deeper 
muscles may not be as easily identified. Further, the spastic muscles can atrophy or twist, 
and these conditions can potentially alter the anatomical location of the muscle itself. In some 
cases, patients are unable to have a standard position that is appropriate for injection as dem-
onstrated by the electrography tests. These conditions result in MNP localization as the sub-
optimal localization [6]. Henzel et al. [7] demonstrated this concept to determine whether 
US localization is equivalent to anatomical localization in order to identify BoNT-A injection 
targets. The investigators were able to locate the forearm spastic muscle using two separate 
localization techniques. The study results showed that significant differences were observed 
between MNP localization and US localization for several flexor muscles. This group believed 
that the landmark measurement was based on cadaveric studies and that it is difficult to place 
patients with spasticity in a standard supination and extension position. Furthermore, in the 
case of in-patients with spasticity, the typical three-dimensional structure of the forearm may 
be distorted due to severe muscle atrophy [8].
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2.2. Electromyography-guided injection
The EMG-guided injection technique is familiar amongst many physicians who treat spastic-
ity using BoNT-A. This injection technique has the ability to precisely identify spastic muscles 
and requires an EMG machine and a hollow insulated monopolar needle electrode [6]. To 
conduct this technique, the physician first ensures that the target muscles align with the ana-
tomical localization and then administers the EMG-guided injection. Once the EMG needle 
electrode is inserted into spastic muscle, the physician should hear the involuntary motor unit 
action potentials (MUAPs), which may initially have a dull muffled sound, but will become 
sharper as the needle is advanced closer to the end plate. In order to make sure that the spastic 
muscle is correctly targeted, the physician may ask the patient to move that muscle, and the 
physician will then listen for increased signalling of MUAPs. In the event that the patient is 
unable to voluntarily contract the muscle using active motions, the physician may conduct a 
passive range of motion (PROM) to stretch the target muscle in the patient [9].
There are several advantages that are associated with the use of EMG-guided injection. An 
auditory EMG device is inexpensive and provides a mechanism for more precisely localizing 
the spastic target muscles. In addition, the EMG-guided injection is helpful for the delivery of 
the BoNT-A near the motor endplate of the spastic muscle or in the location of a high concen-
tration of active MUAPs [10, 11]. There are a few disadvantages associated with EMG-guided 
technique. At first, this technique does not guarantee that the monopolar needle is inserted in 
the target muscle. Voluntary activation and PROM are used to decrease this risk; however, for 
deeper or overlapping muscles, there would be a greater probability for misplacement of the 
needle. In some instances, the physician may inject into a spastic muscle that may not be the 
target muscle. To circumvent these issues, the clinician may increase the frequency and inten-
sity of the muscle stimulus to identify spastic muscle, which may extend the time duration of 
the procedure and intensify the level of pain as compared with anatomic guidance. Other dis-
advantages of the EMG-guided injection technique are the costs of the insulated EMG needle 
and the costs of the EMG machine compare with anatomic guidance [6].
2.3. Electrical stimulation-guided injection
The electrical stimulation-guided injection is a popular technique for muscle localization. In 
this method, like EMG-guided injection, a hollow insulated monopolar needle is connected 
to a portable ES machine, and the target muscle is located by anatomical landmarks. Once 
the needle electrode is located in the target muscle, electric current is delivered to the muscle 
through the needle electrode. Normally, a 5-mA stimulus at 1-Hz intervals is applied to con-
tract the muscle. Once the level of muscle contraction is identified as appropriate, the clinician 
may attempt to maintain a robust contraction while slowly decreasing the intensity of the 
muscle stimulation or incrementally modify the needle electrode, as needed. If the clinician is 
able to maintain the muscle contraction using a low-intensity stimulus, such as a 1 mA, the cli-
nician can be relatively certain that the tip of the needle is proximal to the motor endplate [6].
One advantage of the ES-guided injection technique is the accuracy of the targeted muscle 
localization. The visual feedback from the spastic muscle contraction ensures that the needle 
is properly inserted in the target muscle, especially in the event that muscle contraction occurs 
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under a low-intensity stimulus. The disadvantage of using the ES-guided technique to locate 
the target muscle is that this technique may result in increased time consumption and may 
require additional training compared to the other techniques mentioned herein. Moreover, 
this technique may cause the patient to experience a higher level of discomfort than the other 
techniques. In addition to the disadvantages of the ES-guided technique, for patients with 
severe spasticity and limited range of motion, it may be difficult to assess individual muscle 
contraction. Lastly, the costs of both the needle electrode and the ES device must be consid-
ered in clinical practice when conducting this method.
2.4. Ultrasound-guided injection
Ultrasonography is well established as a reliable and reproducible imaging method that is 
used to identify the anatomy of the muscle [12]. Ultrasound machines consist of several com-
ponents: the transducer, the computer processor unit and the monitor. Transducers are avail-
able in high and low frequencies, while the higher-frequency transducers are used for more 
superficial structures at a high resolution and the lower-frequency transducers can be used to 
assess deeper structures. The clinician who is experienced with the use of US-guided injection 
is able to recognize the cross-sectional anatomy that is displayed on the monitor and is able to 
visualize the needle tip once it is injected into the target muscle.
There are many advantages of the US-guided injection with BoNT-A. This technique allows 
real-time visualization of the needle into structures including the target muscles and adjunct 
tissues. This method not only permits the clinician to more precisely identify the target mus-
cles but also permits the avoidance of needle penetration in some other bodily structures, 
to include the blood vessels and nerves. Other potential benefits of this technique is that 
US-guided technique procedure is relatively more efficient with respect to the time needed to 
conduct this technique, and the patients experience less pain compared with the ES-guided 
and EMG-guided injections. The lowered pain indication can be attributed to the use of a 
smaller gauge needle [7]. In addition, the use of US-guided injection may help to reduce side 
effects of the injected medicine, such as the dissemination of BoNT-A into nontargeted areas. 
Moreover, the clinician is able to visualize the volume of the injected BoNT-A solution in real 
time and administer the appropriate amount of solution into the targeted muscle. This fea-
ture permits the physician to relocate the needle tip to a different area within the same target 
muscle in order to complete the injection and minimize the spread of the BoNT-A solution 
into the adjacent off-target muscles.
Although the US-guided injection technique for BoNT-A is regarded as the most accurate 
method for locating the target muscles, shortcomings exist for this technique. At first, operation 
of the US transducer and the syringe simultaneously may require the presence of an assistant. 
This is particularly necessary for the clinicians who are novel to this technique. It is advisable 
that clinicians who are interested in using the US guidance to localize the target muscle should 
seek the appropriate training in great sufficiency prior to administering this technique.
Which type of guided injection technique is most appropriate to eliminate toxins? Other 
investigators have reviewed and compared these guided injection techniques in details as 
reported in recent publications [4, 6, 13]. First, we believe that the clinicians who will perform 
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the BoNT-A injections for spasticity management should be knowledgeable of the advantages 
and disadvantages of each of the injection techniques as previously discussed. Second, the 
clinicians should undergo combined training experiences in order to adequately explain each 
technique in sufficient detail to the patient and ensure that the appropriate technique aligns 
with the needs of the patient. Finally, one should consider additional factors, such as equip-
ment cost, spastic muscles location when considering the most appropriate guided injection 
technique. Although it seems that each of these localization techniques is superior to the use 
of anatomical localization alone, we believe that the anatomical localization should be the 
established standard when considering the use of an instrument-guided injection technique. 
Further, more studies are needed to determine which combination of localization techniques 
can produce the best clinical outcomes.
3. A review of the studies that administered US-guided BoNT-A injection 
into the upper and lower limb muscles of stroke patients
The use of US is a well-established reliable and reproducible imaging method for defin-
ing muscle anatomy. An ultrasound system with a 7.5-MHz linear transducer can provide 
sufficient resolution for both superficial and deep-seated muscles [14]. As an alternative to 
the electrophysiological techniques, US offers a visually controlled method of injection of 
BoNT-A [15, 16]. Schiano et al. were the first to report on the US-guided BoNT-A injection 
for the treatment of achalasia [17]. Since that time, the advantages of the US-guided BoNT-A 
injection have been recognized, and the use of this technique is becoming more widespread in 
the present years. In the previous years, Berweck and colleagues utilized US-guided injections 
for spastic muscles in children. From the years 2000 to 2003, these investigators administered 
over 6000 injections into 70 different muscles in a total of 350 children. Berweck et al. recom-
mended the use of US to conduct anatomically precise injection of BoNT-A due to the advan-
tageous features of sonography, which is easy, quick, painless and available in most hospitals 
[15, 16]. Until now, the use of US was mostly popular amongst pediatrics, and it seemed that 
the use of US was the obvious choice for spastic muscle identification and injection control [4].
Several studies suggested that the various guided BoNT-A injection techniques such as ES 
guided, EMG guided and US guided showed a greater spasticity reduction in conjunction 
with improved clinical outcomes when compared with MNP localization. In a clinical study 
conducted by Yang et al. [18], MNP into the gastrocnemius muscle (GCM) for BoNT-A injec-
tion in children with spastic cerebral palsy (CP) was investigated to analyze its accuracy and 
effectiveness. The accuracy of MNP by one researcher using anatomic landmarks alone was 
assessed by another researcher who used US visualization prior to BoNT-A injection. These 
researchers found that the MNP was accurately placed into the GCM in 78.7% of cases, with 
the greatest accuracy being with the needle insertion into the medial GCM (92.6%) and the 
lowest accuracy was observed in the lateral GCM (64.7%). These investigators reported that 
the lateral portion of the GCM was thinner than the medial GCM, and this resulted in a greater 
rate of misplaced needle. Injection of the BoNT-A into GCMs using an anatomical landmark 
was an acceptable approach for injection into the medial GCM; however, this approach was 
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not effective when administered in the lateral GCM. Py et al. [19] evaluated the effectiveness 
of injecting BoNT-A into the lower limbs of children with CP using the needle placement 
technique (MNP or US guided). Thirty of the children received US-guided injections, and the 
remainder received injections using anatomical localization. These investigators evaluated 
the gait and the spasticity (Tardieu scale), a functional evaluation (the Gross Motor Function 
Measure) 4 weeks after the injection. Clinical effectiveness was noted in the children receiv-
ing US-guided injections compared with MNP alone, and the “functional effectiveness” was 
also improved in the children with the use of US. The results of the aforementioned studies 
support the concept that the US-guided injection is more effective than the MNP localization 
technique administered in the spastic muscles of patients with CP. In contrast to the study 
conducted by Py et al., Kwon et al. [20] evaluated the clinical outcomes in 32 children with CP 
following BoNT-A injections into the GCMs. These investigators compared the efficacy of ES 
guided and US guided for BoNT-A injections into the GCMs in the children. These researchers 
found no significant differences between the groups according to the scores on the modified 
Ashworth Scale scores (MAS) and the Modified Tardieu Scale (MTS) assessments; however, 
the subscales of the Physician’s Rating Scale significantly improved in children who received 
BoNT-A injections when guided by US. Although similar results showed that spasticity levels 
between the US-guided injection and ES-guided injection were decreased, the investigators 
concluded that the visual feedback provided by the US-guided injection may improve the 
accuracy of the administration of BoNT-A into the GCMs in the children.
To date, a few studies have compared the precision of the MNP and US localization in efforts 
to identify the forearm flexor muscles that will undergo BoNT-A injections in subjects with 
arm spasticity. In an observational study of 18 adult patients with upper extremity spastic-
ity, Henzel et al. [7] explored the accuracy of the MNP to locally administer the investiga-
tional agent in the forearm flexor muscles. After the measurements of the surface, marks were 
obtained, and US was used to determine the optimal injection site, which is described as the 
portion of the target muscle with the largest cross-sectional area. There was a statistically 
significant difference between the proposed injection sites as per the methods of MNP and 
the actual optimal injections sites as determined via the US-guided injections for the flexor 
pollicis longus, pronator teres and flexor digitorum superficialis (FDS) to digit 3, with trends 
towards significance in the flexor carpi radialis and FDS to digits 2 and 4. Based on these find-
ings, the investigators recommend that the US-guided technique should be considered for 
muscle localization in patients with upper extremity spasticity. Picelli et al. [21] completed 
a single-blinded, randomized controlled study comparing the outcomes of 60 chronic stroke 
patients with clenched fist or flexed wrist who underwent BoNT-A injections with MNP 
or ES-guided or US-guided injections. Each subject underwent pre-injection and postinjec-
tion evaluations that included MAS, Tardieu angle and PROM. These investigators found 
enhanced improvement in all of the measurements when comparing the ES group with the 
MNP group. Likewise, the subjects in the US-guided BoNT-A injection group demonstrated 
greater improvement in all of the measurements when compared with the MNP group. There 
was no difference noted in the clinical outcomes when comparing patients who received injec-
tions when guided by ES versus the injections that were guided by US. These authors con-
cluded that the use of ES- and US-guided BoNT-A injections decreases spasticity and results 
in vast improvements in the range of motion when compared to MNP techniques alone.
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Santamato et al. [22] compared the reduction of spasticity and the related finger position at rest 
improvement in post-stroke patients treated with BoNT-A in the wrist and finger flexor limb 
muscles using US-guided injection and MNP localization. In the randomized clinical trial, two 
groups of 15 stroke patients were treated with BoNT-A injections in the wrist and finger flexor 
muscles of the affected upper limb using US-guided injections or MNP localization. The MAS 
and the finger position at rest were measured before and 4 weeks after administration of the 
injections. The results showed the MAS and finger position at rest significantly improved in 
both of the treatment groups, although these clinical outcomes were more effective in patients 
who received the US-guided BoNT-A injection compared to patients injected with BoNT-A 
using MNP localization. The investigators concluded that the US-guided BoNT-A injections 
were capable of improving the clinical outcome more effectively than MNP in post-stroke 
patients with spasticity.
In a study conducted by our team [23], we injected BoNT-A while being guided by US in 
patients with post-stroke wrist and finger flexor muscle spasticity and assessed the clinical 
outcomes following the injection and rehabilitation intervention. The results showed signifi-
cant decreases in the MAS scores of both the finger flexor muscle and wrist flexor muscle at all 
time points after BoNT-A injections in comparison with the baseline scores. Compared with 
the baseline, the PROM of the wrist and finger extensions and the FMA scores of the wrist and 
hand significantly increased (p < 0.001) at 2, 4 and 12 weeks after the injections. We concluded 
that the US-guided injection of BoNT-A combined with rehabilitation exercise decreased the 
spasticity of the wrist and finger flexor muscles and improved the motor function in stroke 
patients up to 12 weeks following the BoNT-A injection.
Based on these aforementioned studies, all of the researchers have suggested that the 
US-guided injection technique is more effective in improving the accuracy of toxin place-
ment in patients with limb spasticity. Most importantly, the US-guided injection is visually 
controlled. In viewing the entire process, the operator gains a better understanding of the 
anatomy of the individual under observation. This enables a more effective and safer tech-
nique selection and assists in the reduction of side effects due to the unintentional spread 
of medicine. Despite the fact that US cannot measure the muscular hyperactivity and detect 
motor endplate regions, the ultrasound images can provide information about muscle size 
and fibrosis, which are all factors that can be important in the decision-making process.
4. A description of the procedures for US-guided BoNT-A injection in 
clinical practices
In order to make US-guided injections feasible and effective in clinical practice, in accordance 
with the practice experience, the authors have developed a set of standardized operational 
procedures that include target muscle identification, the selected probe for upper and muscles 
images, the relationship between the limb and probe positioning, the proper needle types 
used for different muscles, the distance between the injecting needle and probe and needle 
tilting angle and the coordination between the operators and others involved in the injection 
process.
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1. Probe selection
The 7.5-MHz linear transducer can provide sufficient resolution for superficial muscles but is 
also able to detect deep-seated muscles.
2. Probe viewing mode
The transverse viewing mode is arranged such that the medial part of the limb is seen on the 
right and the lateral part of the limb (the right side) is seen on the left side of the monitor screen.
3. Muscle imaging
The musculature appears poorly echogenic, while the perimysia and fascicular tissue between 
the muscle bellies are apparently echogenic. The two principles of muscle identification are 
(1) recognizing the characteristic pattern of the individual muscles. The transverse sonogram 
corresponds to the transverse anatomic sections. (2) Each muscle has a characteristic con-
tour line. These muscles exhibit specific patterns and allow prompt (within a few seconds) 
identification of the individual muscles. An example for the upper or lower limb is shown in 
Figures 1 and 2.
4. Imaging of neighbouring structures
Visualization of the neighbouring structures, such as the bones and vessels, helps to accu-
rately determine the injection site in target muscles. An example is shown in Figure 3.
5. Identification of target muscles
The suggested manner to identify target muscles includes the following: (1) The skin surface 
location for the target muscle was identified on the basis of the use of the specific anatomic 
landmarks from Delagi et al. [5] and was subsequently marked. (2) The transducer was located 
Figure 1. Sonographic image of the upper limb (Bic = bicep, H = humerus).
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at the marker and positioned perpendicularly to the skin surface to obtain a transverse view of 
the target muscle. (3) By adjusting the parameters such as view depth, focus and gain, a clear 
image of the target muscle and other muscles could be displayed (Figures 4–6).
Figure 2. Sonographic image of the lower limb (SOL, soleus; FDL, flexor hallucis longus; TP, tibialis posterior; T, tibia; 
F, fibula).
Figure 3. Sonographic image of the forearm, including the FDL and surrounding structures (Bra, brachioradialis; FPL, 
flexor pollicis longus; FDS, flexor digitorum superficialis; FDP, flexor digitorum profundus; A, artery; R, radius; U, ulna).
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Note 1: Passive movements at small amplitudes are visible as concurrent oscillations of the 
intramuscular echo. Passive movement of the corresponding part of the body may help to 
visualize the dynamic contraction of the target muscle.
6. US-guided injection
To conduct the US-guided injection, (1) in the transverse (axial) view, the target muscle was 
scanned from the proximal to distal direction or vice versa until the largest cross-sectional area 
was identified. (2) The needle was inserted and was closely aligned to the longitudinal axis of 
the transducer (Figure 7). Slight movements of the needle along the transducer longitudinal axis 
are helpful to obtain a satisfactory image. (3) As the needle penetrates the skin, its path through 
the tissue to the target site for injection is continually monitored on the screen. (4) To confirm 
the surface injection site, in some cases, the second injection site of each target muscle was iden-
tified by distally moving the transducer approximately 1.5–2.0 cm. (5) Pre-injection sonographic 
images and the images during the injection are able to be stored for future references.
Upon injection, the solution spreads out in the muscle, usually as an echogenic cloud, some-
times with echo obliteration (Figures 8 and 9).
Note 2: Slight movements of the needle along its longitudinal axis can help to obtain a satis-
factory image.
Figure 4. Probe location at different target muscles (a, pronator teres; b, pronator quadratus).
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Figure 5. Sonographic image of the upper third of the anterior forearm (PT, pronator teres; Bra, brachioradialis; A, 
artery).
Figure 6. Sonographic image of the lower third portion of the anterior forearm (PQ, pronator quadratus; FDS, flexor 
digitorum superficialis; FDP, flexor digitorum profundus; R, radius; U, ulna).
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Figure 7. Sonographic image indicating the position of the inserted needle (arrow head points to the hyperecho line).
Figure 8. Needle in the target muscle before injection (arrow head points to the hyperecho point).
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5. A summary of the necessary skills to effectively administer  
the US-guided BoNT-A injection
1. Familiarity with the regional anatomy of the limb
It is well known that due to the size of the ultrasound probe, the pictures that are displayed 
on the screen of the ultrasound machine are specific only to the regional anatomy of the tissue 
under examination. Therefore, various probe locations result in different sonographic images. 
In order to achieve accurate injections, the clinician should undergo intense practice sessions 
in administering a variety of injections which will allow the clinician to become more familiar 
with the characteristics of the muscle and the surrounding structures as viewed through the 
sonographic machine. These practices are useful for precise injection into the target muscles 
and also ensure a safe and effective injection.
2. Basic operation of the ultrasound machine
The operators of the US machine should be competent in the use of this machine. A good 
understanding of the panel operation is helpful for adjusting the parameter settings in order 
to obtain the best image quality, which in turn would project the best injection site.
3. Spastic limb placement
In preparation of the injection, the injection site of the affected limb should be fully exposed. 
If patients with the higher spasticity levels are unable to position the limb appropriately, the 
clinician should ask for an assistant to help correctly position the limb.
Figure 9. The solution disseminates into the target muscle (arrow head points to the hyperecho area).
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4. The probe placement
The probe should be perpendicular to the plane of the proposed limb for injection. Proper 
probe placement is one of the basic requirements to obtain an excellent quality of ultrasound 
images. If the angle from the probe and body is too large or too small, the probe will receive 
sound reduction. Furthermore, the probe will produce unclear images of anatomical struc-
ture, and the accuracy of the injection will undergo severe alterations.
5. Relationship between the needle and probe (Figures 10 and 11)
In the in-plane position, the needle should be parallel to the probe. Next, the needle is inserted 
along the longitudinal axis of the probe. In this orientation, the needle is easy to visualize and 
the tip can be observed in its entirety during the injection.
In the out-of-plane position, the needle is inserted across the short axis of the probe at an angle 
to the skin. To properly conduct this technique, it is necessary to acquire the skills through 
repetitive practices and obtain a sufficient level of experience. The tip or shaft of the needle 
was seen as a hyper-echoic dot using the method.
The most common choice is the in-plane method in which the needle process can be observed 
throughout the muscle to ensure the safety and accuracy of the injection. In the out-of-plane 
position, the accuracy of injection may be affected due to the fact that only a portion of the 
needle is visible in the sonographic picture.
6. Ambidextrous coordination
As one hand holds the probe, the clinician should pay careful attention to the manner in 
which the probe is handled such that the probe is well positioned on the surface of the 
Figure 10. In plane (needle is parallel to probe).
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skin. Using the other hand, the clinician is capable of the injection using the US-guided 
technique. For beginners, this ambidextrous coordination may seem challenging. With 
repetitive practices and increased exposure to this technique, the clinician will be able to 
master the skills.
7. Other skills
The operators involved with the injection procedure should practise sterile techniques.
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